Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT

Clinical trial NCT06408753 · COMPLETED

Trial details

NCT number: NCT06408753
Sponsor: The University of Hong Kong
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatocellular Carcinoma Non-resectable Stereotactic Body Radiotherapy

Start date: 2019-11-01
Primary completion: 2023-11-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.